Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

China Regenerative Medicine International Limited

中國再生醫學國際有限公司

(Incorporated in the Cayman Islands with limited liability)

(formerly known as "China Bio-Med Regeneration Technology Limited 中國生物醫學再生科技有限公司")

(Stock Code: 8158) CHANGE OF COMPANY NAME, STOCK SHORT NAME AND COMPANY WEBSITE

The Board announces that the English name of the Company has been changed from "China
Bio-Med Regeneration Technology Limited" to "China Regenerative Medicine International Limited" and the Chinese name of the Company has been changed from "中國生物醫學再生 科技有限公司" to "中國再生醫學國際有限公司".
The stock short name of the Shares for trading on the Stock Exchange will be changed from
"CHINA BIO-MED" to "CRMI" in English and from "中國生物醫學" to "中國再生醫學" in
Chinese with effect from 9:00 a.m. on 9 March 2015. The stock code of the Company
remains as "8158".
The corporate website address of the Company is changed from "www.bmregeneration.com" to
"www.crmi.hk" with immediate effect.
Reference is made to the announcement of China Regenerative Medicine International Limited (formerly known as China Bio-Med Regeneration Technology Limited) (the "Company") dated 29 December 2014, the circular of the Company dated 6 January 2015 (the "Circular"), and the announcement of the Company relating to the poll result of the extraordinary general meeting of the Company held on 30 January 2015, in relation to, among other things, the proposed change of company name. Capitalised terms used herein shall have the same
meanings as those defined in the Circular unless otherwise stated.

- 1 -

CHANGE OF COMPANY NAME

The Board announces that the English name of the Company has been changed from "China
Bio-Med Regeneration Technology Limited" to "China Regenerative Medicine International Limited" and the Chinese name of the Company has been changed from "中國生物醫學再生 科技有限公司" to "中國再生醫學國際有限公司". The Certificate of Incorporation on
Change of Name of the Company was issued by the Registrar of Companies in the Cayman Islands on 3 February 2015 and the Certificate of Registration of Alteration of Name of Registered Non-Hong Kong Company was issued by the Registrar of Companies in Hong Kong on 26 February 2015.

CHANGE OF STOCK SHORT NAME

The stock short name of Shares for trading on the Stock Exchange will be changed from
"CHINA BIO-MED" to "CRMI" in English and from "中國生物醫學" to "中國再生醫學" in
Chinese with effect from 9:00 a.m. on 9 March 2015. The stock code of the Company
remains as "8158".

EFFECTS OF THE CHANGE OF COMPANY NAME

The Change of Company Name will not affect any rights of the Shareholders. All the existing share certificates in issue bearing the former name of the Company will continue to be evidence of title to such shares and the existing share certificates will continue to be valid for trading, settlement, registration and delivery purposes. There will not be any arrangement for free exchange of the existing share certificates of the Company for new share certificates bearing the new name of the Company. New share certificates will be issued under the new name of the Company with effect from 9 March 2015.

CHANGE OF COMPANY WEBSITE

The corporate website address of the Company is changed from "www.bmregeneration.com" to
"www.crmi.hk" with immediate effect.

- 2 -

By order of the Board

China Regenerative Medicine International Limited Dai Yumin

Executive Director

Hong Kong, 4 March 2015

As at the date of this announcement, the executive Directors are Mr. Dai Yumin and Ms. Wang Yurong; the non-executive Directors are Mr. Wong Sai Hung, Professor Deng Shaoping, Mr. Cao Fushun, Mr. Yang Zhengguo, Mr. Ma Long and Mr. Wang Jianjun; and the independent non-executive Directors are Mr. Lui Tin Nang, Mr. Chan Wing Hang, Mr. Pang Chung Fai Benny and Mr. Chan Bing Woon, SBS, JP.

This announcement, for which the Directors collectively and individually accept full responsibility, includes particulars given in compliance with the GEM Listing Rules for the purpose of giving information with regard to the Company. The Directors, having made all reasonable enquiries, confirm that to the best of their knowledge and belief the information contained in this announcement is accurate and complete in all material respects and not misleading or deceptive, and there are no other matters the omission of which would make any statement herein or this announcement misleading.

This announcement will remain on the "Latest Company Announcement" page of the GEM website at www.hkgem.com for at least seven days from the date of the publication and will be published on the website of the Company at www.crmi.hk.

- 3 -

distributed by